Ilex Medical Ltd (TLV:ILX)

Market Cap	521.70M -26.1%
Revenue (ttm)	930.83M +1.1%
Net Income	55.56M +42.5%
EPS	4.97 +42.5%
Shares Out	11.19M
PE Ratio	9.39
Forward PE	n/a
Dividend	1.99 (4.22%)
Ex-Dividend Date	Apr 10, 2026

Volume	323
Average Volume	10,981
Open	4,707.00
Previous Close	4,707.00
Day's Range	4,640.00 - 4,778.00
52-Week Range	4,501.00 - 7,085.00
Beta	-0.18
RSI	31.28
Earnings Date	Apr 3, 2026

About Ilex Medical

Ilex Medical Ltd engages in the import, marketing, distribution and sale of medical laboratory equipment and various diagnostic products, diagnostic systems, and kits and consumables in Israel, the United States, and internationally. The company also provides laboratory services, as well as is involved in the development, production, marketing and sale of software systems for information management in medical laboratories. Its products are used for performing tests in hospital medical laboratories, blood banks and health insurance funds, as wel...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1990
• Employees: 181
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: ILX

Financial Performance

In 2025, Ilex Medical's revenue was 930.83 million, an increase of 1.14% compared to the previous year's 920.37 million. Earnings were 55.56 million, an increase of 42.52%.